Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Clinical trial NCT04171141 · TERMINATED

Trial details

NCT number: NCT04171141
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Tumors Colorectal Adenocarcinomas Gastric Adenocarcinomas Esophageal Adenocarcinomas

Start date: 2019-11-19
Primary completion: 2023-11-28
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.